Researchers believe that tesofensine may help treat obese and overweight patients because it boosts the levels of dopamine in the brain
One study found that 90% of individuals experienced adverse side effects in the first eight weeks of treatment, while another study found that 70% of diabetes patients discontinued use after 2 years due to feeling chronically sick
Wegovy (semaglutide) and Mounjaro (tirzepatide) are peptides, and peptides can be broken down in the digestive tract before they are absorbed
For many, a New Year brings resolutions, hope, and excitement
However, you may need someone to help you, as this area can be difficult to reach on your own
Incorporating these medications into a long-term wellness plan involves constant evaluation